MOVFOR is an oral experimental antiviral drug which contains Molnupiravir. It exerts its antiviral action through introduction of copying errors during viral RNA replication.
Molnupiravir is indicated for the treatment of adult patients with Covid-19, SpO2>93% and who have high risk of progression of the disease including hospitalization or death